Form 8-K - Current report:
SEC Accession No. 0001104659-24-026343
Filing Date
2024-02-22
Accepted
2024-02-22 08:20:33
Documents
14
Period of Report
2024-02-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246979d1_8k.htm   iXBRL 8-K 28204
  Complete submission text file 0001104659-24-026343.txt   200421

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20240222.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20240222_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20240222_pre.xml EX-101.PRE 22379
15 EXTRACTED XBRL INSTANCE DOCUMENT tm246979d1_8k_htm.xml XML 3503
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 24662396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)